Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut. more
Time Frame | MNKD | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.74% | -2.12% | -3% |
1-Month Return | -0.44% | -3.42% | -0.73% |
3-Month Return | 3.79% | -11.13% | 2.87% |
6-Month Return | 40.95% | -5.74% | 7.17% |
1-Year Return | 105.4% | 3.97% | 25.31% |
3-Year Return | 56.04% | 1.05% | 28.38% |
5-Year Return | 396.38% | 34.37% | 81.89% |
10-Year Return | -74.54% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 63.04M | 65.14M | 75.44M | 99.77M | 198.96M | [{"date":"2019-12-31","value":31.68,"profit":true},{"date":"2020-12-31","value":32.74,"profit":true},{"date":"2021-12-31","value":37.92,"profit":true},{"date":"2022-12-31","value":50.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 27.98M | 24.64M | 38.86M | 57.50M | 62.77M | [{"date":"2019-12-31","value":44.57,"profit":true},{"date":"2020-12-31","value":39.26,"profit":true},{"date":"2021-12-31","value":61.9,"profit":true},{"date":"2022-12-31","value":91.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 35.06M | 40.50M | 36.59M | 42.27M | 136.19M | [{"date":"2019-12-31","value":25.74,"profit":true},{"date":"2020-12-31","value":29.74,"profit":true},{"date":"2021-12-31","value":26.86,"profit":true},{"date":"2022-12-31","value":31.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 55.62% | 62.17% | 48.49% | 42.37% | 68.45% | [{"date":"2019-12-31","value":81.25,"profit":true},{"date":"2020-12-31","value":90.83,"profit":true},{"date":"2021-12-31","value":70.85,"profit":true},{"date":"2022-12-31","value":61.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 81.57M | 65.29M | 90.07M | 111.19M | 125.60M | [{"date":"2019-12-31","value":64.95,"profit":true},{"date":"2020-12-31","value":51.98,"profit":true},{"date":"2021-12-31","value":71.71,"profit":true},{"date":"2022-12-31","value":88.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (46.51M) | (24.79M) | (53.48M) | (68.92M) | 8.68M | [{"date":"2019-12-31","value":-535.95,"profit":false},{"date":"2020-12-31","value":-285.61,"profit":false},{"date":"2021-12-31","value":-616.31,"profit":false},{"date":"2022-12-31","value":-794.2,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (15.30M) | (18.85M) | (50.37M) | (45.55M) | (38.76M) | [{"date":"2019-12-31","value":-1530200000,"profit":false},{"date":"2020-12-31","value":-1884900000,"profit":false},{"date":"2021-12-31","value":-5036900000,"profit":false},{"date":"2022-12-31","value":-4554600000,"profit":false},{"date":"2023-12-31","value":-3876200000,"profit":false}] |
Pre-Tax Income | (51.90M) | (57.46M) | (80.93M) | (87.40M) | (10.38M) | [{"date":"2019-12-31","value":-5190300000,"profit":false},{"date":"2020-12-31","value":-5745800000,"profit":false},{"date":"2021-12-31","value":-8092600000,"profit":false},{"date":"2022-12-31","value":-8740000000,"profit":false},{"date":"2023-12-31","value":-1037700000,"profit":false}] |
Income Taxes | 7.83M | (218.00K) | 10.87M | 24.77M | 1.56M | [{"date":"2019-12-31","value":31.6,"profit":true},{"date":"2020-12-31","value":-0.88,"profit":false},{"date":"2021-12-31","value":43.87,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.3,"profit":true}] |
Income After Taxes | (59.73M) | (57.24M) | (91.79M) | (112.17M) | (11.94M) | [{"date":"2019-12-31","value":-5972900000,"profit":false},{"date":"2020-12-31","value":-5724000000,"profit":false},{"date":"2021-12-31","value":-9179100000,"profit":false},{"date":"2022-12-31","value":-11216900000,"profit":false},{"date":"2023-12-31","value":-1193800000,"profit":false}] |
Income From Continuous Operations | (51.90M) | (57.24M) | (80.93M) | (87.40M) | (31.29M) | [{"date":"2019-12-31","value":-5190300000,"profit":false},{"date":"2020-12-31","value":-5724000000,"profit":false},{"date":"2021-12-31","value":-8092600000,"profit":false},{"date":"2022-12-31","value":-8740000000,"profit":false},{"date":"2023-12-31","value":-3128600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (59.73M) | (57.24M) | (91.79M) | (112.17M) | (11.94M) | [{"date":"2019-12-31","value":-5972900000,"profit":false},{"date":"2020-12-31","value":-5724000000,"profit":false},{"date":"2021-12-31","value":-9179100000,"profit":false},{"date":"2022-12-31","value":-11216900000,"profit":false},{"date":"2023-12-31","value":-1193800000,"profit":false}] |
EPS (Diluted) | (0.27) | (0.20) | (0.23) | (0.34) | (0.05) | [{"date":"2019-12-31","value":-27,"profit":false},{"date":"2020-12-31","value":-20,"profit":false},{"date":"2021-12-31","value":-23,"profit":false},{"date":"2022-12-31","value":-34,"profit":false},{"date":"2023-12-31","value":-4.57,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
MNKD | |
---|---|
Cash Ratio | 3.49 |
Current Ratio | 4.54 |
Quick Ratio | 4.17 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MNKD | |
---|---|
ROA (LTM) | 9.12% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MNKD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.45 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.45 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MNKD | |
---|---|
Trailing PE | 78.75 |
Forward PE | 34.97 |
P/S (TTM) | 6.50 |
P/B | 0.00 |
Price/FCF | 220 |
EV/R | 6.10 |
EV/Ebitda | 23.69 |
PEG | NM |
MannKind Corp (MNKD) share price today is $6.85
Yes, Indians can buy shares of MannKind Corp (MNKD) on Vested. To buy MannKind Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MNKD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of MannKind Corp (MNKD) via the Vested app. You can start investing in MannKind Corp (MNKD) with a minimum investment of $1.
You can invest in shares of MannKind Corp (MNKD) via Vested in three simple steps:
The 52-week high price of MannKind Corp (MNKD) is $7.63. The 52-week low price of MannKind Corp (MNKD) is $3.17.
The price-to-earnings (P/E) ratio of MannKind Corp (MNKD) is 78.75
The price-to-book (P/B) ratio of MannKind Corp (MNKD) is 0.00
The dividend yield of MannKind Corp (MNKD) is 0.00%
The market capitalization of MannKind Corp (MNKD) is $1.74B
The stock symbol (or ticker) of MannKind Corp is MNKD